Olaparib in Combination With Carboplatin for Refractory or Recurrent Women s Cancers
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Ovarian Cancer|Breast Cancer|Primary Peritoneal Cancer|Fallopian Tube Cancer|Endometrial Cancer
Interventions: DRUG: Carboplatin|DRUG: Olaparib
Sponsor: National Cancer Institute (NCI)